TD Cowen analyst maintained a Buy rating on GoodRx Holdings today and set a price target of $16.00. The company’s shares closed yesterday at $7.92.
GoodRx Holdings has an analyst consensus of Moderate Buy, with a price target consensus of $9.88, implying a 24.75% upside from current levels. (TipRanks)
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.